The University Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, 2006, NSW, Australia.
The Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), Faculty of Health, University of Technology Sydney, 2007, NSW, Australia.
Complement Ther Clin Pract. 2019 May;35:158-169. doi: 10.1016/j.ctcp.2019.02.008. Epub 2019 Feb 13.
To determine the prevalence, characteristics, expenditure and predictors of complementary medicine (CM) use in Australian adults living with gastrointestinal disorders (GID).
A cross-sectional study involving 2,025 Australian adults was conducted. Participants were recruited through purposive convenience sampling. Descriptive statistics were conducted to report the prevalence of people living with GIDs and their CM use, including CM products, mind-body practices and CM practitioner services. Chi-square test and independent-samples t-test were used to determine the associations between sociodemographic or health-related variables with CM use. Binary logistic regression was conducted to determine the significant predictors of CM use in GID participants. Economic data was calculated based on the mean out-of-pocket expenditure on CM.
Of the 293 participants reporting a GID, 186 (63.5%) used CM products, 55 (18.8%) used a mind-body practice and 141 (48.1%) visited at least one CM practitioner in the last 12 months. Collectively, the majority of GID participants using any type of CM were female, aged 40-49 years, married and employed. The mean score for health-related quality of life was 49.6 out of 100 in GID participants and 68.2 in participants without a GID (p < 0.001). Average annual out-of-pocket expenditure on CM products was AUD127.29 by CM products users with a GID. The predictors of CM products, mind-body practices and CM practitioner services use differed. Of the 111 CM product users with a GID, 103 (92.8%) disclosed all or some of their CM use to general practitioner, 89 (80.2%) to specialist doctor, 79 (71.2%) to pharmacist and 69 (62.1%) to hospital doctor.
A substantial proportion of Australian adults living with GID use CM products, mind-body practices and CM practitioner services. This study provides important insights to inform and guide the development of a more coordinated health care services for individuals living with GID.
确定澳大利亚患有胃肠道疾病（GID）的成年人中补充医学（CM）的使用频率、特征、支出和预测因素。
本研究采用横断面研究设计，共纳入 2025 名澳大利亚成年人。参与者通过有针对性的便利抽样招募。采用描述性统计方法报告患有 GID 的人群及其 CM 使用情况，包括 CM 产品、身心实践和 CM 从业者服务。采用卡方检验和独立样本 t 检验确定社会人口统计学或健康相关变量与 CM 使用之间的关联。采用二元逻辑回归确定 GID 参与者使用 CM 的显著预测因素。根据 CM 支出的平均自付额计算经济数据。
在报告患有 GID 的 293 名参与者中，186 名（63.5%）使用了 CM 产品，55 名（18.8%）使用了身心实践，141 名（48.1%）在过去 12 个月内至少访问过一次 CM 从业者。总体而言，大多数使用任何类型 CM 的 GID 参与者为女性，年龄在 40-49 岁之间，已婚且有工作。患有 GID 的参与者的健康相关生活质量平均得分为 100 分中的 49.6 分，而没有 GID 的参与者得分为 68.2 分（p<0.001）。患有 GID 的 CM 产品使用者的平均年度 CM 产品自付额为 127.29 澳元。CM 产品、身心实践和 CM 从业者服务使用的预测因素不同。在 111 名患有 GID 的 CM 产品使用者中，有 103 名（92.8%）向全科医生透露了他们全部或部分 CM 使用情况，89 名（80.2%）向专科医生透露，79 名（71.2%）向药剂师透露，69 名（62.1%）向医院医生透露。
相当一部分澳大利亚患有 GID 的成年人使用 CM 产品、身心实践和 CM 从业者服务。本研究为为患有 GID 的个体提供更协调的医疗保健服务提供了重要的信息和指导。
